Rachel Lenington is the founder of Athira Pharma. Athira Pharma has raised $90M in total funding. Backed by Commodore Capital, Perceptive Advisors, TCGX.
Rachel Lenington is the Chief Technology Officer and Head of Product Development Strategy at Athira Pharma, appointed on June 14, 2021. She brings over 20 years of experience in biopharmaceutical leadership, with prior roles at Seagen Inc., the Bill & Melinda Gates Foundation, and Amgen.
Full founder directory · Investor directory · Company funding database · Fundraising library